Ainos Inc. (NASDAQ:AIMD) price on Friday, March 17, fall -3.85% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $1.50.
A look at the stock’s price movement, the close in the last trading session was $1.56, moving within a range at $1.24 and $1.83. The beta value (5-Year monthly) was 1.04. Turning to its 52-week performance, $18.00 and $0.55 were the 52-week high and 52-week low respectively. Overall, AIMD moved 87.52% over the past month.
Do You Know The Best Place To Find Gains In Volatile Markets?
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free.
Sponsored
Ainos Inc.’s market cap currently stands at around $30.88 million.
Revisions could be used as tool to get short term price movement insight, and for the company that in the past seven days was no upward and no downward review(s).
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 0 recommend AIMD as a Buy and 1 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Overweight which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
AIMD’s current price about 82.11% and 94.40% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 77.14, while 7-day volatility ratio is 31.08% and 14.18% in the 30-day chart. Further, Ainos Inc. (AIMD) has a beta value of 0.99, and an average true range (ATR) of 0.19. Analysts have given the company’s stock an average 52-week price target of $68.85, forecast between a low of $68.85 and high of $68.85. Looking at the price targets, the low is -4490.0% off current price level while to achieve the yearly target high, price needs to move -4490.0%. Nonetheless, investors will most likely welcome a -4490.0% jump to $68.85 which is the analysts’ median price.
In the market, a comparison of Ainos Inc. (AIMD) and its peers suggest the former has performed considerably weaker. Data shows AIMD’s intraday price has changed -3.85% in last session and -76.19% over the past year. Comparatively, TherapeuticsMD Inc. (TXMD) has moved 0.87% on the day and only -80.93% in the past 12 months. Looking at another peer, we see that Ligand Pharmaceuticals Incorporated (LGND) price has dipped -2.18% on the day. However, the stock is 3.07% off its price a year ago. Moreover, BioCryst Pharmaceuticals Inc. (BCRX) is also down -0.86% in trading on the day while keeping a a downtrend of -47.64% over the past year. Elsewhere, the overall performance for the S&P 500 and Dow Jones Industrial shows that the indexes are down -1.10% and -1.19% respectively in the last trading.
If we refocus on Ainos Inc. (NASDAQ:AIMD), historical trading data shows that trading volumes averaged 5.91 million over the past 10 days and 991.34K over the past 3 months. The company’s latest data on shares outstanding shows there are 15.30 million shares.
The 7.70% of Ainos Inc.’s shares are in the hands of company insiders while institutional holders own 0.40% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 29280.0 on Jan 30, 2023, giving us a short ratio of 3.5. The data shows that as of Jan 30, 2023 short interest in Ainos Inc. (AIMD) stood at 0.15% of shares outstanding, with shares short falling to 37670.0 registered in Dec 29, 2022. Current price change has pushed the stock 141.94% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the AIMD stock continues to rise going into the next quarter.
